Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Clinical trial NCT07467993 · RECRUITING
Trial details
- NCT number
- NCT07467993
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-16
- Primary completion
- 2027-07-29
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.